Purity:SDS-PAGE

Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab) is more than 95%, determined by SEC-HPLC.

Bioactivity:ELISA

Immobilized human PD-1 His at 2 ug/mL can bind Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab), EC50=0.0039 ug/mL.

Research in vivo

Pembrolizumab inhibited the tumor growth of MC38 on human PD-1 mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 44.0% at 0.18 mpk at D37.

-25~-15℃保存，有效期1年。